Geron Corporation (GERN) - Latest Market Data

Price & Market Data

Price: $1.30

Daily Change: -$0.09 / 6.92%

Daily Range: $1.29 - $1.45

Market Cap: $885,315,520

Daily Volume: 14,193,778

Performance Metrics

1 Week: 13.04%

1 Month: -9.72%

3 Months: -0.76%

6 Months: -56.95%

1 Year: -71.18%

YTD: -63.28%

Company Details

Employees: 229

Sector: Health technology

Industry: Biotechnology

Country:

Details

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.

Selected stocks

Fortress Biotech, Inc. (FBIO)

Gelteq Limited (GELS)

Reliance Global Group, Inc. (RELI)